The effect of high dose n-acetylcysteine in lupus nephritis patient: a case report and literature review
- At: 2008 FIP Congress in Basel (Switzerland)
- Type: Poster
- By: KARUNRAT, Tewthanom (Faculty of Pharmacy, Silpakorn University, Muang, Thailand)
- Co-author(s): Janwitayanujit, Suchela (Department of medicine, Ramathibodi hospital, Mahidol University, Thailand)
Totemchockchyakarn, Kitti (Department of medicine, Ramathibodi hospital, Mahidol University, Thailand)
Panomvana Na Ayudhaya, Duangchit (Faculty of Pharmaceutical Sciences, Chulalongkorn University, Thailand)
An imbalance of oxidative - antioxidative defence mechanism has been proposed in SLE patients. Co-administration of N-acetylcysteine (NAC) which has a strong antioxidant activity in SLE patients may produce a satisfied therapeutic outcomes. we reported a case of 46-year old women with lupus nephritis who recieved 1,800 mg of NAC parallel with.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.